nodes	percent_of_prediction	percent_of_DWPC	metapath
Tadalafil—PDE5A—clitoris—urinary bladder cancer	0.232	0.494	CbGeAlD
Tadalafil—PDE5A—penis—urinary bladder cancer	0.0658	0.14	CbGeAlD
Tadalafil—PDE11A—prostate gland—urinary bladder cancer	0.0413	0.0878	CbGeAlD
Tadalafil—PDE11A—epithelium—urinary bladder cancer	0.0303	0.0645	CbGeAlD
Tadalafil—PDE5A—prostate gland—urinary bladder cancer	0.0157	0.0334	CbGeAlD
Tadalafil—CYP3A4—urine—urinary bladder cancer	0.0136	0.029	CbGeAlD
Tadalafil—PDE5A—epithelium—urinary bladder cancer	0.0115	0.0246	CbGeAlD
Tadalafil—PDE5A—smooth muscle tissue—urinary bladder cancer	0.0111	0.0237	CbGeAlD
Tadalafil—PDE5A—renal system—urinary bladder cancer	0.0107	0.0228	CbGeAlD
Tadalafil—PDE5A—urethra—urinary bladder cancer	0.0105	0.0224	CbGeAlD
Tadalafil—PDE5A—female reproductive system—urinary bladder cancer	0.00857	0.0182	CbGeAlD
Tadalafil—PDE5A—vagina—urinary bladder cancer	0.00775	0.0165	CbGeAlD
Tadalafil—PDE5A—lymph node—urinary bladder cancer	0.00502	0.0107	CbGeAlD
Tadalafil—CYP3A4—renal system—urinary bladder cancer	0.00334	0.0071	CbGeAlD
Tadalafil—CYP3A4—female reproductive system—urinary bladder cancer	0.00267	0.00569	CbGeAlD
Tadalafil—Dyspnoea—Etoposide—urinary bladder cancer	0.000642	0.00121	CcSEcCtD
Tadalafil—Somnolence—Etoposide—urinary bladder cancer	0.00064	0.00121	CcSEcCtD
Tadalafil—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000639	0.00121	CcSEcCtD
Tadalafil—Epistaxis—Methotrexate—urinary bladder cancer	0.000638	0.0012	CcSEcCtD
Tadalafil—Vomiting—Thiotepa—urinary bladder cancer	0.000637	0.0012	CcSEcCtD
Tadalafil—Infestation NOS—Epirubicin—urinary bladder cancer	0.000633	0.00119	CcSEcCtD
Tadalafil—Infestation—Epirubicin—urinary bladder cancer	0.000633	0.00119	CcSEcCtD
Tadalafil—Rash—Thiotepa—urinary bladder cancer	0.000632	0.00119	CcSEcCtD
Tadalafil—Bronchitis—Doxorubicin—urinary bladder cancer	0.000631	0.00119	CcSEcCtD
Tadalafil—Dermatitis—Thiotepa—urinary bladder cancer	0.000631	0.00119	CcSEcCtD
Tadalafil—Headache—Thiotepa—urinary bladder cancer	0.000628	0.00118	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000627	0.00118	CcSEcCtD
Tadalafil—Renal failure—Epirubicin—urinary bladder cancer	0.000622	0.00117	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000621	0.00117	CcSEcCtD
Tadalafil—Fatigue—Etoposide—urinary bladder cancer	0.000621	0.00117	CcSEcCtD
Tadalafil—Pain—Etoposide—urinary bladder cancer	0.000615	0.00116	CcSEcCtD
Tadalafil—Constipation—Etoposide—urinary bladder cancer	0.000615	0.00116	CcSEcCtD
Tadalafil—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000615	0.00116	CcSEcCtD
Tadalafil—Urinary tract infection—Epirubicin—urinary bladder cancer	0.000615	0.00116	CcSEcCtD
Tadalafil—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000611	0.00115	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.00061	0.00115	CcSEcCtD
Tadalafil—Haemoglobin—Methotrexate—urinary bladder cancer	0.00061	0.00115	CcSEcCtD
Tadalafil—Haemorrhage—Methotrexate—urinary bladder cancer	0.000607	0.00114	CcSEcCtD
Tadalafil—Sweating—Epirubicin—urinary bladder cancer	0.000606	0.00114	CcSEcCtD
Tadalafil—Asthenia—Gemcitabine—urinary bladder cancer	0.000605	0.00114	CcSEcCtD
Tadalafil—Haematuria—Epirubicin—urinary bladder cancer	0.000603	0.00114	CcSEcCtD
Tadalafil—Pharyngitis—Methotrexate—urinary bladder cancer	0.000602	0.00114	CcSEcCtD
Tadalafil—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000599	0.00113	CcSEcCtD
Tadalafil—Epistaxis—Epirubicin—urinary bladder cancer	0.000597	0.00113	CcSEcCtD
Tadalafil—Pruritus—Gemcitabine—urinary bladder cancer	0.000596	0.00113	CcSEcCtD
Tadalafil—Nausea—Thiotepa—urinary bladder cancer	0.000595	0.00112	CcSEcCtD
Tadalafil—Urethral disorder—Methotrexate—urinary bladder cancer	0.000595	0.00112	CcSEcCtD
Tadalafil—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000589	0.00111	CcSEcCtD
Tadalafil—Pruritus—Fluorouracil—urinary bladder cancer	0.000586	0.00111	CcSEcCtD
Tadalafil—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000585	0.0011	CcSEcCtD
Tadalafil—Infestation—Doxorubicin—urinary bladder cancer	0.000585	0.0011	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.00058	0.00109	CcSEcCtD
Tadalafil—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000579	0.00109	CcSEcCtD
Tadalafil—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000577	0.00109	CcSEcCtD
Tadalafil—Renal failure—Doxorubicin—urinary bladder cancer	0.000575	0.00109	CcSEcCtD
Tadalafil—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000574	0.00108	CcSEcCtD
Tadalafil—Urticaria—Etoposide—urinary bladder cancer	0.000572	0.00108	CcSEcCtD
Tadalafil—Haemoglobin—Epirubicin—urinary bladder cancer	0.000571	0.00108	CcSEcCtD
Tadalafil—Rhinitis—Epirubicin—urinary bladder cancer	0.000569	0.00107	CcSEcCtD
Tadalafil—Abdominal pain—Etoposide—urinary bladder cancer	0.000569	0.00107	CcSEcCtD
Tadalafil—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000569	0.00107	CcSEcCtD
Tadalafil—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000569	0.00107	CcSEcCtD
Tadalafil—Haemorrhage—Epirubicin—urinary bladder cancer	0.000568	0.00107	CcSEcCtD
Tadalafil—Eye disorder—Methotrexate—urinary bladder cancer	0.000567	0.00107	CcSEcCtD
Tadalafil—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000567	0.00107	CcSEcCtD
Tadalafil—Tinnitus—Methotrexate—urinary bladder cancer	0.000566	0.00107	CcSEcCtD
Tadalafil—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000565	0.00107	CcSEcCtD
Tadalafil—Asthenia—Cisplatin—urinary bladder cancer	0.000564	0.00106	CcSEcCtD
Tadalafil—Pharyngitis—Epirubicin—urinary bladder cancer	0.000564	0.00106	CcSEcCtD
Tadalafil—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000563	0.00106	CcSEcCtD
Tadalafil—Sweating—Doxorubicin—urinary bladder cancer	0.000561	0.00106	CcSEcCtD
Tadalafil—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000561	0.00106	CcSEcCtD
Tadalafil—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000559	0.00106	CcSEcCtD
Tadalafil—Haematuria—Doxorubicin—urinary bladder cancer	0.000558	0.00105	CcSEcCtD
Tadalafil—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000558	0.00105	CcSEcCtD
Tadalafil—Urethral disorder—Epirubicin—urinary bladder cancer	0.000557	0.00105	CcSEcCtD
Tadalafil—Epistaxis—Doxorubicin—urinary bladder cancer	0.000552	0.00104	CcSEcCtD
Tadalafil—Angiopathy—Methotrexate—urinary bladder cancer	0.000551	0.00104	CcSEcCtD
Tadalafil—Immune system disorder—Methotrexate—urinary bladder cancer	0.000548	0.00103	CcSEcCtD
Tadalafil—Dizziness—Fluorouracil—urinary bladder cancer	0.000548	0.00103	CcSEcCtD
Tadalafil—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000547	0.00103	CcSEcCtD
Tadalafil—Diarrhoea—Cisplatin—urinary bladder cancer	0.000538	0.00101	CcSEcCtD
Tadalafil—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000537	0.00101	CcSEcCtD
Tadalafil—Vomiting—Gemcitabine—urinary bladder cancer	0.000536	0.00101	CcSEcCtD
Tadalafil—Mental disorder—Methotrexate—urinary bladder cancer	0.000532	0.001	CcSEcCtD
Tadalafil—Rash—Gemcitabine—urinary bladder cancer	0.000531	0.001	CcSEcCtD
Tadalafil—Dermatitis—Gemcitabine—urinary bladder cancer	0.000531	0.001	CcSEcCtD
Tadalafil—Eye disorder—Epirubicin—urinary bladder cancer	0.000531	0.001	CcSEcCtD
Tadalafil—Hypersensitivity—Etoposide—urinary bladder cancer	0.00053	0.001	CcSEcCtD
Tadalafil—Tinnitus—Epirubicin—urinary bladder cancer	0.000529	0.000999	CcSEcCtD
Tadalafil—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000528	0.000996	CcSEcCtD
Tadalafil—Headache—Gemcitabine—urinary bladder cancer	0.000528	0.000996	CcSEcCtD
Tadalafil—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000527	0.000994	CcSEcCtD
Tadalafil—Flushing—Epirubicin—urinary bladder cancer	0.000527	0.000994	CcSEcCtD
Tadalafil—Vomiting—Fluorouracil—urinary bladder cancer	0.000527	0.000994	CcSEcCtD
Tadalafil—Rhinitis—Doxorubicin—urinary bladder cancer	0.000527	0.000994	CcSEcCtD
Tadalafil—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000525	0.000991	CcSEcCtD
Tadalafil—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000523	0.000986	CcSEcCtD
Tadalafil—Rash—Fluorouracil—urinary bladder cancer	0.000523	0.000986	CcSEcCtD
Tadalafil—Dermatitis—Fluorouracil—urinary bladder cancer	0.000522	0.000985	CcSEcCtD
Tadalafil—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000522	0.000984	CcSEcCtD
Tadalafil—Headache—Fluorouracil—urinary bladder cancer	0.000519	0.00098	CcSEcCtD
Tadalafil—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000519	0.000979	CcSEcCtD
Tadalafil—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000518	0.000977	CcSEcCtD
Tadalafil—Asthenia—Etoposide—urinary bladder cancer	0.000516	0.000974	CcSEcCtD
Tadalafil—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000516	0.000974	CcSEcCtD
Tadalafil—Angiopathy—Epirubicin—urinary bladder cancer	0.000515	0.000972	CcSEcCtD
Tadalafil—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000515	0.000972	CcSEcCtD
Tadalafil—Immune system disorder—Epirubicin—urinary bladder cancer	0.000513	0.000968	CcSEcCtD
Tadalafil—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000512	0.000966	CcSEcCtD
Tadalafil—Back pain—Methotrexate—urinary bladder cancer	0.000511	0.000964	CcSEcCtD
Tadalafil—Pruritus—Etoposide—urinary bladder cancer	0.000509	0.000961	CcSEcCtD
Tadalafil—Nausea—Gemcitabine—urinary bladder cancer	0.000501	0.000945	CcSEcCtD
Tadalafil—Vomiting—Cisplatin—urinary bladder cancer	0.0005	0.000943	CcSEcCtD
Tadalafil—Vision blurred—Methotrexate—urinary bladder cancer	0.000498	0.000939	CcSEcCtD
Tadalafil—Mental disorder—Epirubicin—urinary bladder cancer	0.000498	0.000939	CcSEcCtD
Tadalafil—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000497	0.000937	CcSEcCtD
Tadalafil—Rash—Cisplatin—urinary bladder cancer	0.000495	0.000935	CcSEcCtD
Tadalafil—Dermatitis—Cisplatin—urinary bladder cancer	0.000495	0.000934	CcSEcCtD
Tadalafil—Diarrhoea—Etoposide—urinary bladder cancer	0.000492	0.000929	CcSEcCtD
Tadalafil—Nausea—Fluorouracil—urinary bladder cancer	0.000492	0.000929	CcSEcCtD
Tadalafil—Eye disorder—Doxorubicin—urinary bladder cancer	0.000491	0.000927	CcSEcCtD
Tadalafil—Tinnitus—Doxorubicin—urinary bladder cancer	0.00049	0.000924	CcSEcCtD
Tadalafil—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000488	0.00092	CcSEcCtD
Tadalafil—Flushing—Doxorubicin—urinary bladder cancer	0.000488	0.00092	CcSEcCtD
Tadalafil—Back pain—Epirubicin—urinary bladder cancer	0.000478	0.000902	CcSEcCtD
Tadalafil—Angiopathy—Doxorubicin—urinary bladder cancer	0.000477	0.000899	CcSEcCtD
Tadalafil—Dizziness—Etoposide—urinary bladder cancer	0.000476	0.000898	CcSEcCtD
Tadalafil—Muscle spasms—Epirubicin—urinary bladder cancer	0.000475	0.000897	CcSEcCtD
Tadalafil—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000475	0.000895	CcSEcCtD
Tadalafil—Vertigo—Methotrexate—urinary bladder cancer	0.000475	0.000895	CcSEcCtD
Tadalafil—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000474	0.000894	CcSEcCtD
Tadalafil—Nausea—Cisplatin—urinary bladder cancer	0.000467	0.000881	CcSEcCtD
Tadalafil—Vision blurred—Epirubicin—urinary bladder cancer	0.000466	0.000879	CcSEcCtD
Tadalafil—Cough—Methotrexate—urinary bladder cancer	0.000461	0.00087	CcSEcCtD
Tadalafil—Mental disorder—Doxorubicin—urinary bladder cancer	0.00046	0.000869	CcSEcCtD
Tadalafil—Convulsion—Methotrexate—urinary bladder cancer	0.000458	0.000864	CcSEcCtD
Tadalafil—Vomiting—Etoposide—urinary bladder cancer	0.000458	0.000863	CcSEcCtD
Tadalafil—Rash—Etoposide—urinary bladder cancer	0.000454	0.000856	CcSEcCtD
Tadalafil—Dermatitis—Etoposide—urinary bladder cancer	0.000453	0.000855	CcSEcCtD
Tadalafil—Headache—Etoposide—urinary bladder cancer	0.000451	0.000851	CcSEcCtD
Tadalafil—Myalgia—Methotrexate—urinary bladder cancer	0.00045	0.000849	CcSEcCtD
Tadalafil—Arthralgia—Methotrexate—urinary bladder cancer	0.00045	0.000849	CcSEcCtD
Tadalafil—Chest pain—Methotrexate—urinary bladder cancer	0.00045	0.000849	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000447	0.000843	CcSEcCtD
Tadalafil—Discomfort—Methotrexate—urinary bladder cancer	0.000444	0.000838	CcSEcCtD
Tadalafil—Vertigo—Epirubicin—urinary bladder cancer	0.000444	0.000838	CcSEcCtD
Tadalafil—Syncope—Epirubicin—urinary bladder cancer	0.000443	0.000836	CcSEcCtD
Tadalafil—Back pain—Doxorubicin—urinary bladder cancer	0.000442	0.000835	CcSEcCtD
Tadalafil—Muscle spasms—Doxorubicin—urinary bladder cancer	0.00044	0.00083	CcSEcCtD
Tadalafil—Palpitations—Epirubicin—urinary bladder cancer	0.000437	0.000824	CcSEcCtD
Tadalafil—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000434	0.00082	CcSEcCtD
Tadalafil—Cough—Epirubicin—urinary bladder cancer	0.000431	0.000814	CcSEcCtD
Tadalafil—Vision blurred—Doxorubicin—urinary bladder cancer	0.000431	0.000813	CcSEcCtD
Tadalafil—Convulsion—Epirubicin—urinary bladder cancer	0.000428	0.000808	CcSEcCtD
Tadalafil—Infection—Methotrexate—urinary bladder cancer	0.000428	0.000808	CcSEcCtD
Tadalafil—Nausea—Etoposide—urinary bladder cancer	0.000428	0.000807	CcSEcCtD
Tadalafil—Hypertension—Epirubicin—urinary bladder cancer	0.000427	0.000805	CcSEcCtD
Tadalafil—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000423	0.000798	CcSEcCtD
Tadalafil—Chest pain—Epirubicin—urinary bladder cancer	0.000421	0.000794	CcSEcCtD
Tadalafil—Myalgia—Epirubicin—urinary bladder cancer	0.000421	0.000794	CcSEcCtD
Tadalafil—Arthralgia—Epirubicin—urinary bladder cancer	0.000421	0.000794	CcSEcCtD
Tadalafil—Skin disorder—Methotrexate—urinary bladder cancer	0.000419	0.00079	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000418	0.000789	CcSEcCtD
Tadalafil—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000417	0.000786	CcSEcCtD
Tadalafil—Discomfort—Epirubicin—urinary bladder cancer	0.000416	0.000785	CcSEcCtD
Tadalafil—Dry mouth—Epirubicin—urinary bladder cancer	0.000412	0.000777	CcSEcCtD
Tadalafil—Vertigo—Doxorubicin—urinary bladder cancer	0.000411	0.000775	CcSEcCtD
Tadalafil—Syncope—Doxorubicin—urinary bladder cancer	0.00041	0.000774	CcSEcCtD
Tadalafil—Palpitations—Doxorubicin—urinary bladder cancer	0.000404	0.000763	CcSEcCtD
Tadalafil—Oedema—Epirubicin—urinary bladder cancer	0.000403	0.000761	CcSEcCtD
Tadalafil—Hypotension—Methotrexate—urinary bladder cancer	0.000403	0.00076	CcSEcCtD
Tadalafil—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000402	0.000759	CcSEcCtD
Tadalafil—Infection—Epirubicin—urinary bladder cancer	0.000401	0.000756	CcSEcCtD
Tadalafil—Cough—Doxorubicin—urinary bladder cancer	0.000399	0.000753	CcSEcCtD
Tadalafil—Shock—Epirubicin—urinary bladder cancer	0.000397	0.000749	CcSEcCtD
Tadalafil—Convulsion—Doxorubicin—urinary bladder cancer	0.000396	0.000748	CcSEcCtD
Tadalafil—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000396	0.000747	CcSEcCtD
Tadalafil—Hypertension—Doxorubicin—urinary bladder cancer	0.000395	0.000745	CcSEcCtD
Tadalafil—Tachycardia—Epirubicin—urinary bladder cancer	0.000394	0.000743	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000393	0.000741	CcSEcCtD
Tadalafil—Skin disorder—Epirubicin—urinary bladder cancer	0.000392	0.000739	CcSEcCtD
Tadalafil—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.00039	0.000736	CcSEcCtD
Tadalafil—Insomnia—Methotrexate—urinary bladder cancer	0.00039	0.000736	CcSEcCtD
Tadalafil—Arthralgia—Doxorubicin—urinary bladder cancer	0.000389	0.000735	CcSEcCtD
Tadalafil—Myalgia—Doxorubicin—urinary bladder cancer	0.000389	0.000735	CcSEcCtD
Tadalafil—Chest pain—Doxorubicin—urinary bladder cancer	0.000389	0.000735	CcSEcCtD
Tadalafil—Paraesthesia—Methotrexate—urinary bladder cancer	0.000387	0.00073	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000387	0.00073	CcSEcCtD
Tadalafil—Discomfort—Doxorubicin—urinary bladder cancer	0.000385	0.000726	CcSEcCtD
Tadalafil—Dyspnoea—Methotrexate—urinary bladder cancer	0.000384	0.000725	CcSEcCtD
Tadalafil—Somnolence—Methotrexate—urinary bladder cancer	0.000383	0.000723	CcSEcCtD
Tadalafil—Dry mouth—Doxorubicin—urinary bladder cancer	0.000381	0.000719	CcSEcCtD
Tadalafil—Dyspepsia—Methotrexate—urinary bladder cancer	0.000379	0.000716	CcSEcCtD
Tadalafil—Hypotension—Epirubicin—urinary bladder cancer	0.000377	0.000711	CcSEcCtD
Tadalafil—Oedema—Doxorubicin—urinary bladder cancer	0.000373	0.000704	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000372	0.000702	CcSEcCtD
Tadalafil—Fatigue—Methotrexate—urinary bladder cancer	0.000372	0.000701	CcSEcCtD
Tadalafil—Infection—Doxorubicin—urinary bladder cancer	0.000371	0.0007	CcSEcCtD
Tadalafil—Pain—Methotrexate—urinary bladder cancer	0.000369	0.000696	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000368	0.000694	CcSEcCtD
Tadalafil—Shock—Doxorubicin—urinary bladder cancer	0.000367	0.000693	CcSEcCtD
Tadalafil—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000366	0.000691	CcSEcCtD
Tadalafil—Insomnia—Epirubicin—urinary bladder cancer	0.000365	0.000689	CcSEcCtD
Tadalafil—Tachycardia—Doxorubicin—urinary bladder cancer	0.000364	0.000687	CcSEcCtD
Tadalafil—Skin disorder—Doxorubicin—urinary bladder cancer	0.000363	0.000684	CcSEcCtD
Tadalafil—Paraesthesia—Epirubicin—urinary bladder cancer	0.000362	0.000684	CcSEcCtD
Tadalafil—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000361	0.000681	CcSEcCtD
Tadalafil—Dyspnoea—Epirubicin—urinary bladder cancer	0.00036	0.000679	CcSEcCtD
Tadalafil—Somnolence—Epirubicin—urinary bladder cancer	0.000359	0.000677	CcSEcCtD
Tadalafil—Dyspepsia—Epirubicin—urinary bladder cancer	0.000355	0.00067	CcSEcCtD
Tadalafil—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000353	0.000665	CcSEcCtD
Tadalafil—Hypotension—Doxorubicin—urinary bladder cancer	0.000349	0.000658	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000348	0.000657	CcSEcCtD
Tadalafil—Fatigue—Epirubicin—urinary bladder cancer	0.000348	0.000656	CcSEcCtD
Tadalafil—Pain—Epirubicin—urinary bladder cancer	0.000345	0.000651	CcSEcCtD
Tadalafil—Constipation—Epirubicin—urinary bladder cancer	0.000345	0.000651	CcSEcCtD
Tadalafil—Urticaria—Methotrexate—urinary bladder cancer	0.000342	0.000646	CcSEcCtD
Tadalafil—Abdominal pain—Methotrexate—urinary bladder cancer	0.000341	0.000643	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.00034	0.000642	CcSEcCtD
Tadalafil—Insomnia—Doxorubicin—urinary bladder cancer	0.000338	0.000637	CcSEcCtD
Tadalafil—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000335	0.000632	CcSEcCtD
Tadalafil—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000333	0.000628	CcSEcCtD
Tadalafil—Somnolence—Doxorubicin—urinary bladder cancer	0.000332	0.000626	CcSEcCtD
Tadalafil—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.00033	0.000622	CcSEcCtD
Tadalafil—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000329	0.00062	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000322	0.000608	CcSEcCtD
Tadalafil—Fatigue—Doxorubicin—urinary bladder cancer	0.000322	0.000607	CcSEcCtD
Tadalafil—Urticaria—Epirubicin—urinary bladder cancer	0.000321	0.000605	CcSEcCtD
Tadalafil—Pain—Doxorubicin—urinary bladder cancer	0.000319	0.000602	CcSEcCtD
Tadalafil—Constipation—Doxorubicin—urinary bladder cancer	0.000319	0.000602	CcSEcCtD
Tadalafil—Abdominal pain—Epirubicin—urinary bladder cancer	0.000319	0.000602	CcSEcCtD
Tadalafil—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000318	0.000599	CcSEcCtD
Tadalafil—Asthenia—Methotrexate—urinary bladder cancer	0.000309	0.000584	CcSEcCtD
Tadalafil—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000305	0.000576	CcSEcCtD
Tadalafil—Pruritus—Methotrexate—urinary bladder cancer	0.000305	0.000576	CcSEcCtD
Tadalafil—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000297	0.000561	CcSEcCtD
Tadalafil—Urticaria—Doxorubicin—urinary bladder cancer	0.000297	0.00056	CcSEcCtD
Tadalafil—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000295	0.000557	CcSEcCtD
Tadalafil—Diarrhoea—Methotrexate—urinary bladder cancer	0.000295	0.000557	CcSEcCtD
Tadalafil—Asthenia—Epirubicin—urinary bladder cancer	0.000289	0.000546	CcSEcCtD
Tadalafil—Pruritus—Epirubicin—urinary bladder cancer	0.000285	0.000539	CcSEcCtD
Tadalafil—Dizziness—Methotrexate—urinary bladder cancer	0.000285	0.000538	CcSEcCtD
Tadalafil—Diarrhoea—Epirubicin—urinary bladder cancer	0.000276	0.000521	CcSEcCtD
Tadalafil—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000275	0.000519	CcSEcCtD
Tadalafil—Vomiting—Methotrexate—urinary bladder cancer	0.000274	0.000517	CcSEcCtD
Tadalafil—Rash—Methotrexate—urinary bladder cancer	0.000272	0.000513	CcSEcCtD
Tadalafil—Dermatitis—Methotrexate—urinary bladder cancer	0.000272	0.000512	CcSEcCtD
Tadalafil—Headache—Methotrexate—urinary bladder cancer	0.00027	0.00051	CcSEcCtD
Tadalafil—Asthenia—Doxorubicin—urinary bladder cancer	0.000268	0.000505	CcSEcCtD
Tadalafil—Dizziness—Epirubicin—urinary bladder cancer	0.000267	0.000503	CcSEcCtD
Tadalafil—Pruritus—Doxorubicin—urinary bladder cancer	0.000264	0.000498	CcSEcCtD
Tadalafil—Vomiting—Epirubicin—urinary bladder cancer	0.000257	0.000484	CcSEcCtD
Tadalafil—Nausea—Methotrexate—urinary bladder cancer	0.000256	0.000483	CcSEcCtD
Tadalafil—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000255	0.000482	CcSEcCtD
Tadalafil—Rash—Epirubicin—urinary bladder cancer	0.000254	0.00048	CcSEcCtD
Tadalafil—Dermatitis—Epirubicin—urinary bladder cancer	0.000254	0.00048	CcSEcCtD
Tadalafil—Headache—Epirubicin—urinary bladder cancer	0.000253	0.000477	CcSEcCtD
Tadalafil—Dizziness—Doxorubicin—urinary bladder cancer	0.000247	0.000466	CcSEcCtD
Tadalafil—Nausea—Epirubicin—urinary bladder cancer	0.00024	0.000452	CcSEcCtD
Tadalafil—Vomiting—Doxorubicin—urinary bladder cancer	0.000237	0.000448	CcSEcCtD
Tadalafil—Rash—Doxorubicin—urinary bladder cancer	0.000235	0.000444	CcSEcCtD
Tadalafil—Dermatitis—Doxorubicin—urinary bladder cancer	0.000235	0.000444	CcSEcCtD
Tadalafil—Headache—Doxorubicin—urinary bladder cancer	0.000234	0.000441	CcSEcCtD
Tadalafil—Nausea—Doxorubicin—urinary bladder cancer	0.000222	0.000418	CcSEcCtD
